Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy

(Euronext Amsterdam:NL0000009538),(NYSE:PHG), December 1, 2025 Commercial availability expanded across Europe and the United States Real-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular procedures LumiGuide seamlessly integrates with Azurion, Philips' proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, […]

STMicroelectronics announces status of common share repurchase program

(Paris:STMPA),(NYSE:STM), STMicroelectronics announces status of common share repurchase program Disclosure of Transactions in Own Shares – Period from November 24, 2025 to November 25, 2025 AMSTERDAM – December 01, 2025 — STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common

ProQR to Participate in 8th Annual Evercore Healthcare Conference

(NasdaqGM:PRQR), LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer(TM) RNA editing technology platform, today announced that the Company will participate in a fireside chat at the 8th Annual Evercore Healthcare

Minitap Raises $4.1M to Make Mobile Development 10x Faster with AI

San Francisco, Dec. 01, 2025 (GLOBE NEWSWIRE) — Minitap, the AI-powered mobile development platform, today announced it has raised $4.1 million in seed funding co-led by Moxxie Ventures and Mercuri, with participation from EWOR, Tekton Ventures, Amigos Venture Capital, and six unicorn founders. The round comes just four months after Minitap founders achieved the #1

MAX Power Accelerates CEO Transition as Lawson Enters Next Phase of Natural Hydrogen Testing

MAX Power Accelerates CEO Transition as Lawson Enters Next Phase of Natural Hydrogen Testing Accelerated start for Ran Narayanasamy as CEO aligns with service rig mobilization at Lawson, multi-well follow-up at Bracken and continued buildout of AI-assisted Large Earth Model Integration (MAXX LEMI) with unparalleled data for Natural Hydrogen covering millions of acres in Saskatchewan

Enerflex Ltd. Announces $400 Million Senior Unsecured Notes Offering

Enerflex Ltd. Announces $400 Million Senior Unsecured Notes Offering GlobeNewswire December 01, 2025 CALGARY, Alberta, Dec. 01, 2025 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today announced that Enerflex Inc., a wholly owned subsidiary of Enerflex (the “Issuer”), commenced a private offering (the “Offering”) to eligible purchasers of $400

Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference

Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference GlobeNewswire December 01, 2025 BOSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) — Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation in one-on-one meetings with investors at the RBC Capital Markets Healthcare

Plug Begins First NASA Liquid Hydrogen Contract, Opening New Market in the Growing Space Industry

Plug Begins First NASA Liquid Hydrogen Contract, Opening New Market in the Growing Space Industry Contract beginning today will supply up to 218,000 kilograms of liquid hydrogen to NASA's Glenn and Armstrong facilities GlobeNewswire December 01, 2025 SLINGERLANDS, N.Y., Dec. 01, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard(TM) MRD Platform as Part of Strategic Alliance with Tongshu Gene

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard(TM) MRD Platform as Part of Strategic Alliance with Tongshu Gene GlobeNewswire December 01, 2025 KUALA LUMPUR, Malaysia and SINGAPORE, Dec. 01, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (“BGLC”) today announced that it has executed an Exclusive Intellectual

Tectonic Therapeutic to Participate in December Investor Conferences

Tectonic Therapeutic to Participate in December Investor Conferences GlobeNewswire December 01, 2025 WATERTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company

Scroll to Top